Clinical Trial: Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
COVID-19
Coronavirus Infections
Respiratory Tract Infections
COVID-19 Respiratory Inf
Study Type: Interventional
Official Title: Multicentre, Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Efficacy and Safety of the Coronavirus Vaccine in Healthy Volunteers Aged 18 Years and Older
Brief Summary:
The goal of this clinical trial is to assess the immunogenicity, efficacy and safety of the Convacell vaccine in healthy adult volunteers aged 18 years and older. The main questions it aims to answer are:To assess the immunogenicity and safety of single and double dose intramuscular administration of the Convacell vaccine;To assess the epidemiological effectiveness of the Convacell vaccine in the prevention of SARS-CoV-2 infection and development of severe COVID-19 compared with placebo when single or double…
Read more